BioSpace News Archive

Ultraviolet (UV) technology developed by the New York-based firm PurpleSun Inc. eliminates more than 96 percent of pathogens in operating rooms (ORs) and on medical equipment, compared to 38 percent using manual cleaning methods that rely on chemicals to disinfect surfaces, according to a study published this month in the American Journal of Infection Control (AJIC).

QuadMed, a leader in worksite health and wellness solutions, and BSG Analytics, LLC (BSGA), a nationally recognized health care data analytics firm, today announced a strategic partnership focused on strengthening client reporting and advancing population health.

Jupiter Medical Center is pleased to announce an affiliation with Sylvester Comprehensive Cancer Center at the University of Miami Leonard M. Miller School of Medicine, providing access to groundbreaking cancer treatments to residents in Palm Beach County and the Treasure Coast.

Adamas Pharmaceuticals, Inc. announced that Neil F. McFarlane, the Company’s Chief Executive Officer, is scheduled to present at the following investor conferences

Simplify Medical Pty Ltd, maker of the Simplify® cervical artificial disc, announced the International Society for the Advancement of Spine Surgery has selected two abstracts on the Simplify Disc for podium presentations at the 20th Annual Conference.

Catalyst Biosciences, Inc., announced its operating and financial results for the fourth quarter and full-year ending December 31, 2019 and provided a corporate update.

EyePoint Pharmaceuticals, Inc., a biopharmaceutical company committed to developing and commercializing innovative ophthalmic products, announced that it intends to offer and sell shares of its common stock in an underwritten public offering.

Second European source of donor red blood cells secured in preparation for expanded production of red blood cell-based therapeutics LYON, France and CAMBRIDGE, Mass., Feb. 20, 2020 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext: ERYP - Nasdaq: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating drug substances inside red blood cells, today announced that it has entered into a strategic partnership with the German Red Cross Blood Donor Service Ba

BILLERICA, Mass., Feb. 20, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS) announced today that it will host a webcast and conference call on Monday, March 2, 2020, at 4:30 p.m. Eastern Time to discuss its financial results for the fourth quarter and fiscal year ended December 31, 2019. The webcast will be live at: https://edge.media-server.com/mmc/p/4n3s4un4 . To attend by telephone, please use the information below for dial-in access. When prompted on dial-in, please utilize

SALT LAKE CITY , Feb. 20, 2020 /PRNewswire/ -- ARUP Laboratories announced today that the Food and Drug Administration (FDA) has filed ARUP’s premarket approval application (PMA) for an AAV5 total antibody assay. The assay is intended as a companion diagnostic test for valoctocogene roxaparvovec, BioMarin’s investigational gene therapy treatment for severe hemophilia A.